Showing results (161-170 of 301) with videos related to

Sort By:
Pageof 31
Diabetes, Obesity & Metabolism|September 19, 2018
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterolGregory A Nichols, Sephy Philip, Kristi Reynolds, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 2018
Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL CholesterolGregory A Nichols, Sephy Philip, Kristi Reynolds, et al.
Cardiovascular Research|August 7, 2016
Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol loweringGiuseppe Danilo Norata, Hagai Tavori, Angela Pirillo, et al.
Journal of Clinical Lipidology|November 1, 2022
Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular diseaseJing Gu, Robert J Sanchez, Ankita Chauhan, et al.
Scientific Reports|January 25, 2019
Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor<sup>-/-</sup> Mice Improves Indices of Cardiometabolic DiseaseLinda S May-Zhang, Zhongyi Chen, Noura S Dosoky, et al.
Scientific Reports|March 9, 2019
Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretionLeslie R Sedgeman, Carine Beysen, Marisol A Ramirez Solano, et al.
The Journal of Clinical Investigation|March 4, 2021
Macrophage SR-BI modulates autophagy via VPS34 complex and PPARα transcription of Tfeb in atherosclerosisHuan Tao, Patricia G Yancey, John L Blakemore, et al.
International Journal of Molecular Sciences|June 27, 2024
Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell FormationJaemi Kim, Ji-Yun Kim, Hye-Eun Byeon, et al.
Diabetes, Obesity & Metabolism|November 20, 2019
Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real-world evidencePeter P Toth, Sergio Fazio, Nathan D Wong, et al.
Journal of Clinical Lipidology|May 28, 2019
Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapyBruce A Warden, Jessica Minnier, Gerald F Watts, et al.
Pageof 31